Literature DB >> 22009256

[How can early detection programs become a men's health topic? Survey of urology practices].

M Mathers1, R Reichel, U Nadig, S Roth.   

Abstract

BACKGROUND: Various statistics demonstrate the importance of medical prevention in men.
METHOD: As one example, overall survival is increased with the early diagnosis of prostate cancer. In this article information from 212 consecutive patients with an appointment in a urology practice is presented and discussed. Of special interest are factors that motivate men to participate in early detection programs for prostate cancer. The data give an insight into reasoning and motivation for men to participate in such programs and criteria to select a specific urology practice.
RESULTS: The results, which also include diagnostic methods that are not covered by the general German health insurance and have to be paid by the patient himself, can help the urologist promote diagnostic tools and identify areas of deficit. A key role is played by the family physician. Our results show that he is the primary source for health-related questions. He has the best opportunity to draw the attention of the mature and critical patient to measures of precaution and emphasize their importance. This is especially true for the large group of men who so far have not participated in early detection programs since they apparently are not aware of their own personal health risk.

Entities:  

Mesh:

Year:  2011        PMID: 22009256     DOI: 10.1007/s00120-011-2705-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  9 in total

Review 1.  Personalised risk communication for informed decision making about taking screening tests.

Authors:  A G K Edwards; R Evans; J Dundon; S Haigh; K Hood; G J Elwyn
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

2.  Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.

Authors:  Heidi A van Vugt; Monique J Roobol; Lionne D F Venderbos; Evelien Joosten-van Zwanenburg; Marie-Louise Essink-Bot; Ewout W Steyerberg; Chris H Bangma; Ida J Korfage
Journal:  Eur J Cancer       Date:  2010-02       Impact factor: 9.162

3.  Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors.

Authors:  Alfredo Nicolosi; Edward O Laumann; Dale B Glasser; Edson D Moreira; Anthony Paik; Clive Gingell
Journal:  Urology       Date:  2004-11       Impact factor: 2.649

4.  Uninformed consent: mass screening for prostate cancer.

Authors:  Stewart Justman
Journal:  Bioethics       Date:  2010-05-17       Impact factor: 1.898

5.  [Social gradient of PSA screening? 8 years follow up from the cancer registry of the tumor center in Regensburg].

Authors:  T Klotz; M J Mathers; M Gerken; M Klinkhammer-Schalke; F Hofstädter
Journal:  Urologe A       Date:  2010-12       Impact factor: 0.639

6.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

7.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

8.  [Practice marketing. Data analysis of a urological group practice].

Authors:  T Schneider; B Schneider; A Eisenhardt; H Sperling
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

9.  [Informed consent for patients on early recognition of prostate carcinoma is insufficient].

Authors:  C Börgermann; F vom Dorp; R Rossi; M Schenck; H-J Luboldt; H Rübben
Journal:  Urologe A       Date:  2009-09       Impact factor: 0.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.